Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Clinical Study of Personalized Neoantigen Peptide Vaccines for Solid Tumors

NCT07002203 is registered in ClinicalTrials.gov with Seqker Biosciences, Inc. as lead sponsor.

NCT NCT07002203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07002203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Clinical Study of Personalized Neoantigen Peptide Vaccines for Solid Tumors
Lead sponsor
Seqker Biosciences, Inc.
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 1, 2024
Completion date
August 31, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, neoantigen-specific immunotherapy, personalized cancer vaccine, recurrent cancer, solid tumors